Office of Corporate Alliances, University of Rochester Medical Center

Connecting corporate and academic researchers to advance science and human health

  

 

Research strengths

Ophthalmology/University of Rochester Eye Institute

Learn more about our faculty and their research interestsMission: The ophthalmologists and researchers of the University of Rochester Eye Institute develop and apply new treatments and technologies for the preservation, enhancement and restoration of vision. The Eye Institute is investigating the causes of macular degeneration, glaucoma, diabetic retinopathy and other diseases -- research that could lead to new targeted treatments. The Eye Institute also is producing groundbreaking work in refractive surgery, corneal disease and technology.

Summary: Eye Institute researchers are utilizing adaptive optics technology to observe individual cells in the retina and to study the early development of diseases of the eye. These early disease stages could be linked to genetic factors, providing clues for the development of new treatments. Institute scientists are searching for specific genetic factors required for the growth of neurons in the retina. They also are testing ways to restore vision after damage to the brain. Adaptive optics systems allow researchers to see the inside of the eye in extraordinary detail without harming the eye. Institute researchers are working on ways to improve the technology and to use it to develop customized contact lenses that would correct imperfections in the eye. Scientists also are investigating the effects of contact lens wear on the eye and the nature of tear production. Each aspect of the research agenda aims to preserve, improve or restore vision.

Technology Transfer and Business Development Successes: Ten patent applications were filed in 2004-2005.

Leadership:

Steven E. Feldon, MD
Director, University of Rochester Eye Institute
Chairman, Department of Ophthalmology

NIH Funding: $14.5 million

Major Funded Projects

Facilities: A second phase of construction that will begin in late 2005 will add 20,000 square feet for basic and translational research. The first phase tripled clinical space to 20,000 square feet. The Eye Institute's goal is 70,000 square feet for clinical care and research.

Resource Highlights: Advanced in vivo imaging technologies, such as adaptive optics, fluorescence imaging and Optical Coherence Tomography. Clinical and research lasers. Visual psychophysics in human and animal model systems. Clinical trials coordinating center.

Faculty and Scientific Research